Aprepitant Capsule
Product Images NDC 0781-2322

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Aprepitant (NDC 0781-2322). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sandoz Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

125mg 6ct Carton

Packaging label for Aprepitant Capsules, USP 125 mg, oral capsules by Sandoz Inc. The label indicates a pack of 6 capsules. It includes warnings about blister integrity and notes the unit-dose package is not child-resistant, intended for institutional use only. The label features the Sandoz logo and NDC 0781-2323-68.*

FDA Label Image

125mg 80mg Carton

Label for Aprepitant Capsules, USP by Sandoz Inc, showing strengths of 125 mg and 80 mg oral capsules. The label indicates a 3-capsule package size with specific instructions for days 1, 2, and 3 dosing using yellow (125 mg) and red (80 mg) capsules. Packaging includes storage, dosage, and child safety warnings along with manufacturer information.*

FDA Label Image

40mg 1ct Carton

Packaging label for Aprepitant Capsule, USP 40 mg oral capsules by Sandoz Inc. The label displays the drug name, strength (40 mg), dosage form (capsule), prescription status (Rx Only), a warning about blister integrity, and storage instructions. It indicates the product is for institutional use and includes the NDC number 0781-2321-06 along with batch and expiration imprint areas.*

FDA Label Image

40mg 5ct Carton

Packaging label for Aprepitant Capsules USP 40 mg by Sandoz Inc. The carton holds 5 oral capsules. It includes dosing and storage instructions, a barcode, and manufacturer information indicating production in India by Lek Pharmaceuticals for Sandoz Inc. The label highlights the strength as 40 mg and features warnings about blister integrity and child-resistant packaging.*

FDA Label Image

80mg 2ct Carton

Aprepitant Capsules, USP 80 mg oral capsules by Sandoz Inc. The label indicates a prescription drug with 2 capsules per package, each containing 80 mg of aprepitant. Directions for use and removal instructions are illustrated, including folding, pulling out the card, and pushing capsules through foil. The label includes safety warnings and dosing day indications.*

FDA Label Image

80mg 6ct Carton

Packaging label for Aprepitant Capsules, USP 80 mg by Sandoz Inc, a Novartis Division. The label states the product contains 6 capsules, is for prescription use only, and includes warnings about blister integrity and child resistance. The label features the NDC number 0781-2322-68 and storage instructions.*

FDA Label Image

Figure 1

This image displays two Kaplan-Meier survival curves from two studies comparing the aprepitant regimen against standard therapy over time measured in hours. Each graph shows the percent of patients on the y-axis and hours on the x-axis, illustrating differences in patient outcomes between the treatment groups.*

FDA Label Image

Figure 2

Two bar charts comparing the percentage of patients by chemotherapy cycle for Aprepitant regimen versus Standard therapy. Each chart shows patient percentages on the y-axis and chemotherapy cycles 2 to 6 on the x-axis, displaying trends for two separate studies with sample sizes listed below each chart.*

FDA Label Image

Figure 3

A line graph comparing the percent of patients over 48 hours for Aprepitant 40 mg versus Ondansetron. The x-axis represents hours from 0 to 48, and the y-axis shows percent of patients from 0 to 100%. Two lines show patient response rates: a solid line for Aprepitant 40 mg (N=292) and a dashed line for Ondansetron (N=279).*

FDA Label Image

Structural Formula

Chemical structure of aprepitant as represented in the image. The diagram shows the molecular framework including rings and functional groups characteristic of the active ingredient aprepitant.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.